Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer

Abstract Low-coverage whole-genome sequencing (LC-WGS) can provide insight into oncogenic molecular changes. Serum extracellular vesicles (EV) represent a novel liquid biopsy source of tumoral DNA. This study compared copy number alteration (CNA) profiles generated from LC-WGS of formalin-fixed para...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bella Nguyen, Nicholas C. Wong, Tim Semple, Michael Clark, Stephen Q. Wong, Connull Leslie, Bob Mirzai, Michael Millward, Katie Meehan, Annette M. Lim
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a36570840ea1407d81af8c168aa6556e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a36570840ea1407d81af8c168aa6556e
record_format dspace
spelling oai:doaj.org-article:a36570840ea1407d81af8c168aa6556e2021-12-02T14:03:45ZLow-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer10.1038/s41598-021-83436-12045-2322https://doaj.org/article/a36570840ea1407d81af8c168aa6556e2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83436-1https://doaj.org/toc/2045-2322Abstract Low-coverage whole-genome sequencing (LC-WGS) can provide insight into oncogenic molecular changes. Serum extracellular vesicles (EV) represent a novel liquid biopsy source of tumoral DNA. This study compared copy number alteration (CNA) profiles generated from LC-WGS of formalin-fixed paraffin-embedded (FFPE) tumoral DNA and EV-DNA obtained from cancer patients. Patients with squamous cell carcinoma of the base of tongue (n = 3) and cutaneous squamous cell carcinoma (n = 2) were included. LC-WGS (0.5-1X coverage) was performed on FFPE-DNA and serum EV-DNA. Similarity between CNA profiles was analysed using QDNAseq. FFPE samples had a mean CNA of 31 (range 17–50) over 1.9 × 109 (range 1.0–2.6 × 109) bp in length, and EV samples had a mean CNA value of 17 (range 7–19) over 7.6 × 108 (range 2.9–15 × 108) bp in length. A mean of 8 (range 0–21) CNA over 5.9 × 108 (range 1.6–14 × 108) bp in length was found to overlap between EV and FFPE-derived samples per patient. Although the mean correlation efficient between samples was r = 0.34 (range − .08 to 0.99), this was not statistically significant (p > 0.05). Regions of highest deletion and duplication in FFPE samples were not well reflected in the EV-DNA. Selected CNA regions in EV-associated DNA were reflective of the primary tumor, however appreciation of global CNA and areas of most significant change was lost. The utility of LC-WGS of EV-derived DNA is likely limited to molecular alterations of known interest.Bella NguyenNicholas C. WongTim SempleMichael ClarkStephen Q. WongConnull LeslieBob MirzaiMichael MillwardKatie MeehanAnnette M. LimNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Bella Nguyen
Nicholas C. Wong
Tim Semple
Michael Clark
Stephen Q. Wong
Connull Leslie
Bob Mirzai
Michael Millward
Katie Meehan
Annette M. Lim
Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer
description Abstract Low-coverage whole-genome sequencing (LC-WGS) can provide insight into oncogenic molecular changes. Serum extracellular vesicles (EV) represent a novel liquid biopsy source of tumoral DNA. This study compared copy number alteration (CNA) profiles generated from LC-WGS of formalin-fixed paraffin-embedded (FFPE) tumoral DNA and EV-DNA obtained from cancer patients. Patients with squamous cell carcinoma of the base of tongue (n = 3) and cutaneous squamous cell carcinoma (n = 2) were included. LC-WGS (0.5-1X coverage) was performed on FFPE-DNA and serum EV-DNA. Similarity between CNA profiles was analysed using QDNAseq. FFPE samples had a mean CNA of 31 (range 17–50) over 1.9 × 109 (range 1.0–2.6 × 109) bp in length, and EV samples had a mean CNA value of 17 (range 7–19) over 7.6 × 108 (range 2.9–15 × 108) bp in length. A mean of 8 (range 0–21) CNA over 5.9 × 108 (range 1.6–14 × 108) bp in length was found to overlap between EV and FFPE-derived samples per patient. Although the mean correlation efficient between samples was r = 0.34 (range − .08 to 0.99), this was not statistically significant (p > 0.05). Regions of highest deletion and duplication in FFPE samples were not well reflected in the EV-DNA. Selected CNA regions in EV-associated DNA were reflective of the primary tumor, however appreciation of global CNA and areas of most significant change was lost. The utility of LC-WGS of EV-derived DNA is likely limited to molecular alterations of known interest.
format article
author Bella Nguyen
Nicholas C. Wong
Tim Semple
Michael Clark
Stephen Q. Wong
Connull Leslie
Bob Mirzai
Michael Millward
Katie Meehan
Annette M. Lim
author_facet Bella Nguyen
Nicholas C. Wong
Tim Semple
Michael Clark
Stephen Q. Wong
Connull Leslie
Bob Mirzai
Michael Millward
Katie Meehan
Annette M. Lim
author_sort Bella Nguyen
title Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer
title_short Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer
title_full Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer
title_fullStr Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer
title_full_unstemmed Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer
title_sort low-coverage whole-genome sequencing of extracellular vesicle-associated dna in patients with metastatic cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/a36570840ea1407d81af8c168aa6556e
work_keys_str_mv AT bellanguyen lowcoveragewholegenomesequencingofextracellularvesicleassociateddnainpatientswithmetastaticcancer
AT nicholascwong lowcoveragewholegenomesequencingofextracellularvesicleassociateddnainpatientswithmetastaticcancer
AT timsemple lowcoveragewholegenomesequencingofextracellularvesicleassociateddnainpatientswithmetastaticcancer
AT michaelclark lowcoveragewholegenomesequencingofextracellularvesicleassociateddnainpatientswithmetastaticcancer
AT stephenqwong lowcoveragewholegenomesequencingofextracellularvesicleassociateddnainpatientswithmetastaticcancer
AT connullleslie lowcoveragewholegenomesequencingofextracellularvesicleassociateddnainpatientswithmetastaticcancer
AT bobmirzai lowcoveragewholegenomesequencingofextracellularvesicleassociateddnainpatientswithmetastaticcancer
AT michaelmillward lowcoveragewholegenomesequencingofextracellularvesicleassociateddnainpatientswithmetastaticcancer
AT katiemeehan lowcoveragewholegenomesequencingofextracellularvesicleassociateddnainpatientswithmetastaticcancer
AT annettemlim lowcoveragewholegenomesequencingofextracellularvesicleassociateddnainpatientswithmetastaticcancer
_version_ 1718392099257188352